Effects of Soft Tissue Mobilization Technique and Piriformis Muscle Stretching Among Patients Having Piriformis Syndrome

It is a randomized control trail in which soft tissue mobilization and piriformis stretching will be compared and study duration will be of five months

Study Overview

• Status: Completed
• Conditions: Piriformis Syndrome
• Intervention / Treatment: Other: Soft Tissue mobilization; Other: Piriformis Syndrome (Piriformis muscle stretching)

Detailed Description

Piriformis syndrome is one of the misdiagnosed syndromes and there is no evidence available for the proper diagnosis of this syndrome. Several interventions have been adopted in the clinical setting for improvement of piriformis syndrome including therapeutic ultrasound, myofascial release, stretching, dry needling, strengthening exercises of hip muscles and activity modification. There are several treatments available for this syndrome but no comparison studies have been reported yet on soft tissue mobilization and piriformis muscle stretching. The purpose for conducting this research is to assist in establishing the effectiveness of soft tissue mobilization technique and piriformis muscle stretching in piriformis syndrome by comparison between two abovementioned treatments

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Pakistan
  • Federal
    • Islamabad, Federal, Pakistan, 44010
      • Physiotherapy Clinic Iqra University Islamabad (Chak Shahzad)

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 25 years to 45 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Males and females with age between 25 and 45 years
• Patients with positive piriformis test
• Pain at least 3 according to numeric pain rating scale (NPRS)

Exclusion Criteria:

• History of hip pain due to any diagnosed hip pathology
• Leg length discrepancy
• Past history of spinal surgery
• Spinal tuberculosis
• Rheumatoid disease,

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Group 1; Soft tissue mobilization	Other: Soft Tissue mobilization; mobilization of soft tissues of body
Active Comparator: Group 2; Piriformis Stretching	Other: Piriformis Syndrome (Piriformis muscle stretching); Stretching of Piriformis muscle

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Numeric Pain Rating Scale	Zero means non pain and 10 Means worst type of pain	1 week
Modified Oswestry Disability Index (ODI) questionnaire	A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed-bound	1 Week

Collaborators and Investigators

• Sponsor: Neuro Counsel Hospital, Pakistan
• Collaborators: Physiotherapy Clinic Iqra University Islamabad (Chak Shahzad); Noor Hospital Tarnol, Islamabad
• Investigators: Principal Investigator: Muhammad Kamran, M.Phil*, Al Nafees medical College Hospital

Study record dates

Study Major Dates

• Study Start (Actual): October 2, 2022
• Primary Completion (Actual): December 25, 2022
• Study Completion (Actual): December 26, 2022

Study Registration Dates

• First Submitted: December 26, 2022
• First Submitted That Met QC Criteria: January 10, 2023
• First Posted (Estimate): January 11, 2023

Study Record Updates

• Last Update Posted (Estimate): January 11, 2023
• Last Update Submitted That Met QC Criteria: January 10, 2023
• Last Verified: December 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Nervous System Diseases; Pain; Neurologic Manifestations; Disease; Neuromuscular Diseases; Sciatic Neuropathy; Mononeuropathies; Peripheral Nervous System Diseases; Neuralgia; Nerve Compression Syndromes; Pelvic Pain; Syndrome; Piriformis Muscle Syndrome
• Other Study ID Numbers: 339

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No
• IPD Plan Description: Have not decided yet

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No